Humana Inc. (NYSE:HUM)’s share price fell 7.6% during trading on Thursday . The company traded as low as $160.97 and last traded at $166.28, with a volume of 2,172,837 shares traded. The stock had previously closed at $179.98.

A number of brokerages recently commented on HUM. JPMorgan Chase & Co. downgraded shares of Humana from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $196.00 to $150.00 in a research note on Friday. Credit Suisse Group AG restated a “hold” rating on shares of Humana in a research note on Tuesday, June 28th. Wolfe Research initiated coverage on shares of Humana in a research note on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 price objective for the company. Leerink Swann restated an “outperform” rating on shares of Humana in a research note on Tuesday, June 21st. Finally, Morgan Stanley restated a “hold” rating on shares of Humana in a research note on Sunday, May 22nd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company. Humana presently has a consensus rating of “Hold” and an average price target of $206.00.

The company has a market capitalization of $23.57 billion and a P/E ratio of 22.05. The stock’s 50-day moving average price is $180.60 and its 200 day moving average price is $175.55.

Humana (NYSE:HUM) last released its earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.81 by $0.05. The company earned $13.80 billion during the quarter, compared to the consensus estimate of $13.80 billion. During the same period in the previous year, the firm posted $2.58 EPS. Humana’s revenue for the quarter was down .2% on a year-over-year basis. Equities analysts anticipate that Humana Inc. will post $8.87 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Stockholders of record on Thursday, June 30th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.73%. The ex-dividend date is Tuesday, June 28th.

Several large investors recently added to or reduced their stakes in HUM. Morgan Stanley increased its stake in Humana by 68.6% in the fourth quarter. Morgan Stanley now owns 1,347,032 shares of the insurance provider’s stock valued at $240,459,000 after buying an additional 547,940 shares during the last quarter. Whitebox Advisors LLC raised its position in Humana by 282.1% in the fourth quarter. Whitebox Advisors LLC now owns 250,507 shares of the insurance provider’s stock valued at $44,718,000 after buying an additional 184,940 shares during the period. Vanguard Group Inc. raised its position in Humana by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 8,460,931 shares of the insurance provider’s stock valued at $1,510,361,000 after buying an additional 181,672 shares during the period. Marshall Wace LLP raised its position in Humana by 450.5% in the fourth quarter. Marshall Wace LLP now owns 171,008 shares of the insurance provider’s stock valued at $30,527,000 after buying an additional 139,942 shares during the period. Finally, BBR Partners LLC acquired a new position in Humana during the fourth quarter valued at approximately $23,699,000.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.